ClinicalTrials.Veeva

Menu

Prevention of Iron Deficiency in Breastfed Infants

United States Department of Health and Human Services (HHS) logo

United States Department of Health and Human Services (HHS)

Status and phase

Completed
Phase 4

Conditions

Anemia
Iron Deficiency

Treatments

Dietary Supplement: Fer-in-Sol
Other: control

Study type

Interventional

Funder types

Other
NIH

Identifiers

Details and patient eligibility

About

With early screening and appropriate iron supplementation, iron deficiency in the first year of life can be prevented in breastfed infants.

Full description

Infants with low ferritin at 1 month are at high risk of iron deficiency. They will receive iron drops starting at 2 months. All other infants are at low risk of iron deficiency. All infants will receive iron-fortified cereal starting at 4 months of age.

Enrollment

219 patients

Sex

All

Ages

4 weeks to 9 months old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Term infants
  • gestational age 37-42 weeks
  • birth weight > 2500 g
  • exclusively breastfed at 28 d of age
  • intend to breast feed until 9 mo of age

Exclusion criteria

  • supplemental formula before 4 mo of age

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

219 participants in 2 patient groups

Intervention
Active Comparator group
Description:
Fer-in-Sol drops and iron-fortified cereal
Treatment:
Dietary Supplement: Fer-in-Sol
Control
Other group
Description:
No intervention
Treatment:
Other: control

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems